| CREBBP |
CREBBP, CBP: CREB-binding protein |
SREBF2 |
IPI00478350 |
3.855 |
Evidence |
|
| CREBBP |
CREBBP, CBP: CREB-binding protein |
PHF8 |
PHF8, KIAA1111, ZNF422: PHD finger protein 8 |
3.855 |
Evidence |
|
| GAB1 |
GAB1: GRB2-associated-binding protein 1 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
3.855 |
Evidence |
|
| STRN3 |
STRN3, GS2NA, SG2NA: Striatin-3 |
PCAF |
PCAF: Histone acetyltransferase PCAF |
3.855 |
Evidence |
|
| STRN3 |
STRN3, GS2NA, SG2NA: Striatin-3 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
3.855 |
Evidence |
|
| GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
3.855 |
Evidence |
|
| PPID |
PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase |
MAP3K14 |
MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 |
3.855 |
Evidence |
|
| RELA |
RELA, NFKB3: Transcription factor p65 |
TERF2 |
TERF2, TRBF2, TRF2: Telomeric repeat-binding factor 2 |
3.855 |
Evidence |
|
| GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
3.855 |
Evidence |
|
| MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
MAPK7 |
mitogen-activated protein kinase 7 isoform 1 |
3.855 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
CHUK |
IPI00556043 |
3.855 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
PHF8 |
PHF8, KIAA1111, ZNF422: PHD finger protein 8 |
3.855 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
GAB1 |
GAB1: GRB2-associated-binding protein 1 |
3.855 |
Evidence |
|
| CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
AHNAK |
AHNAK: AHNAK protein |
3.855 |
Evidence |
|
| COPA |
COPA: Coatomer subunit alpha |
MAP3K14 |
MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 |
3.855 |
Evidence |
|
| BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
3.855 |
Evidence |
|
| BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
3.855 |
Evidence |
|
| MRE11A |
MRE11A, HNGS1, MRE11: Double-strand break repair protein MRE11A |
OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
3.855 |
Evidence |
|
| GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
MNAR |
PELP1, HMX3, MNAR: Proline-, glutamic acid- and leucine-rich protein 1 |
3.855 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
RBM6 |
RBM6, DEF3: RNA-binding protein 6 |
3.855 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
MAPK7 |
mitogen-activated protein kinase 7 isoform 1 |
3.855 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
MYBBP1A |
MYBBP1A, P160: Myb-binding protein 1A |
3.855 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
RNPS1 |
RNPS1, LDC2: RNA-binding protein with serine-rich domain 1 |
3.855 |
Evidence |
|
| NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
CHUK |
IPI00556043 |
3.855 |
Evidence |
|
| SAT |
SAT1, SAT: Diamine acetyltransferase 1 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
3.855 |
Evidence |
|